Fraunhofer Cluster of Excellence Immune-Mediated Diseases (CIMD)
Research facility
Location:
Frankfurt am Main,
Germany (DE)
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis (2023)
Fitzgerald O, Behrens F, Barton A, Bertheusen H, Boutouyrie-Dumont B, Coates L, Davies O, et al.
Journal article, Review article
Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021)
Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al.
Conference contribution